Treating patients with Crohn’s disease (CD) successfully, and earlier, can substantially offset their risk for long-term disability and the need for eventual surgical intervention. However, monitoring whether that treatment is successfully achieving its goals traditionally relies on endoscopy and all of its inherent limitations. The possibility that serum and fecal biomarkers of disease activity might …
Read More
